Mission

ActoGeniX’s mission is to develop and commercialize innovative biological therapies, to improve the treatment and well-being of patients with gastrointestinal, immunological and metabolic diseases.

The Company was founded to address the growing need for more effective and safer medications in these important therapeutic areas. To achieve this ambitious goal, ActoGeniX has been applying its proprietary technology platform to create a rich pipeline of ActoBiotics™ .

  1. 23/06/2012

    Biotechdag, 23 June 2012

  2. 13/06/2012

    The Biopharmaceutical Conference in Europe, Cannes, 13-15 June 2012

  3. 24/05/2012

    Knowledge for Growth 2012, ICC Gent, 24 May 2012